While its use in the treatment of coronavirus is still controversial, Morocco maintains its medical protocol based on chloroquine against the pandemic. The Moroccan Minister of Health explains and defends its effectiveness.
While the WHO has decided to temporarily suspend clinical trials with hydroxychloroquine, Morocco maintains its use.
The maintenance is confirmed by the Minister of Health, Khalid Aït Taleb. The latter, however, confides that “opinions differ. But the bottom line is that chloroquine is involved in viral inactivation”. “The virus infects the host by entering the cell in several stages. One of the stages is inhibited by chloroquine”, he insisted.
At the beginning of May, the minister stated on television that the use of chloroquine “gives good results”. According to him, “everyone sees it on the ground. It is not only we who say this, but the same observation is made internationally.”
In addition, according to Aït Tayeb, this treatment can reduce viral load “very quickly”. “We found from the adoption of this treatment on March 23, that patients healed faster than those admitted to hospital before them,” he said, stressing that this protocol can reduce viral load in 6 or 7 days , in addition to allowing the patient not to go to intensive care.
The recent decision of the WHO follows the publication of a study in the medical journal “The Lancet” judging “ineffective even harmful the use of chloroquine or its derivatives like hydroxychloroquine against Covid-19”.
For its part, the French infectious disease specialist Didier Raoult criticized the article published by “The Lancet” deeming it “messy” because it was carried out “by people who have not seen patients”.
“How do you want a messy study done with + big data + to change what we have?” said Didier Raoult of the Institut hospitalo-universitaire (IHU) Méditerranée Infection in Marseille (south of France), in a video posted on the establishment’s website.